IRIS
GABANO, Elisabetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.320
EU - Europa 3.864
AS - Asia 2.312
SA - Sud America 480
AF - Africa 82
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 1
Totale 11.067
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.185
IE - Irlanda 1.083
SG - Singapore 717
DE - Germania 685
CN - Cina 550
SE - Svezia 550
HK - Hong Kong 436
UA - Ucraina 415
BR - Brasile 382
IT - Italia 326
FI - Finlandia 260
RU - Federazione Russa 259
VN - Vietnam 253
IN - India 132
CA - Canada 93
GB - Regno Unito 93
FR - Francia 61
AR - Argentina 38
IR - Iran 36
KR - Corea 34
MX - Messico 34
PL - Polonia 32
BJ - Benin 30
BD - Bangladesh 28
ID - Indonesia 28
BE - Belgio 22
ZA - Sudafrica 22
TR - Turchia 21
JP - Giappone 20
ES - Italia 18
EC - Ecuador 17
LT - Lituania 14
AT - Austria 11
NL - Olanda 11
EG - Egitto 10
PY - Paraguay 10
UZ - Uzbekistan 10
VE - Venezuela 9
CL - Cile 8
EU - Europa 8
IQ - Iraq 8
RO - Romania 8
CO - Colombia 7
MA - Marocco 6
PK - Pakistan 6
AL - Albania 5
SA - Arabia Saudita 5
TN - Tunisia 5
AZ - Azerbaigian 4
JO - Giordania 4
PE - Perù 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
HR - Croazia 3
IL - Israele 3
KE - Kenya 3
HU - Ungheria 2
LB - Libano 2
NG - Nigeria 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GY - Guiana 1
HN - Honduras 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
ML - Mali 1
MY - Malesia 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 11.067
Salva come PNG Salva come JPEG
Città #
Dublin 1.075
Jacksonville 747
Hong Kong 435
Dearborn 412
Singapore 289
Beijing 261
Ashburn 259
New York 222
Chandler 217
Wilmington 186
Ann Arbor 146
Los Angeles 138
Lawrence 134
Princeton 134
Piemonte 104
Moscow 99
Ho Chi Minh City 96
San Mateo 90
Andover 84
Munich 83
Buffalo 68
Toronto 53
Bremen 50
Grafing 49
São Paulo 48
Hanoi 47
Novara 40
Seoul 34
Redondo Beach 32
Santa Clara 32
Dallas 31
Cotonou 30
Helsinki 27
Orem 27
Denver 26
Frankfurt am Main 26
Stockholm 22
Houston 21
Leawood 21
Montreal 21
Warsaw 21
Atlanta 20
Brooklyn 20
Brussels 20
Tokyo 20
Cave Creek 19
Hefei 19
London 19
Nanjing 19
Monmouth Junction 18
Woodbridge 18
Zanjan 18
Boardman 15
Kunming 15
Mexico City 15
Norwalk 15
Biên Hòa 14
Nuremberg 14
Poplar 14
Rio de Janeiro 14
Chennai 13
Chicago 13
Johannesburg 12
Augusta 11
Da Nang 11
Haiphong 11
Kocaeli 11
Seattle 11
Guangzhou 10
Jinan 10
Manchester 10
Mumbai 10
Phoenix 10
Tianjin 10
Turku 10
Ankara 9
Ardabil 9
Bexley 9
Boston 9
Fairfield 9
Jakarta 9
Milan 9
Tashkent 9
Turin 9
Curitiba 8
Hebei 8
Wroclaw 8
Belo Horizonte 7
Campinas 7
Ninh Bình 7
San Francisco 7
Udine 7
Vienna 7
Wuhan 7
Cairo 6
Fortaleza 6
Hải Dương 6
Mülheim 6
Quito 6
Ribeirão Preto 6
Totale 6.616
Salva come PNG Salva come JPEG
Nome #
Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen 137
Cisplatin and valproate released from the bifunctional [Pt(IV)Cl2(NH3)2(valproato)2] antitumor prodrug or from liposome formulations: who does what? 128
195Pt NMR chemical shift: a chemometric approach 125
Transition metal carbonyl clusters in biology: A futile or niche research area? 123
Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells 122
Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure-activity relationship modeling 120
Assessment of the anticancer potentiality of a new platinum nanoparticulate coniugate 118
Antiproliferative Activity of PtII Complexes with Carboxylated Phosphanes in Chelated or Ring-Opened Forms 118
Beyond the Pt(II)-based chemotherapy: Pt(IV) complexes as oral anticancer pro-drugs 116
Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs 116
Different strategies to exploit Pt(IV) complexes as pro-drugs 114
Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs 113
A different way for the oxidation of the Pt(II) complexes 110
The antiproliferative activity of dicobalt-hexacarbonyl-aspirin complex on different malignant pleural mesotelioma phenotypes 109
A New Entry to Asymmetric Platinum(IV) Complexes via Oxidative Chlorination 109
Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 107
Moving the paradigm in platinum-based chemotherapy from Pt(II) to Pt(IV) complexes? 106
Cytotoxicity of some Pt(II)-diamine complexes: a QSAR evaluation of the effect of chelating arms and leaving groups 104
Estradiol as Carrier For Selective Delivery of Cytotoxic Pt(II) Complexes to Cancer Cell Nuclei 103
Experimental (RP-HPLC) and theoretical (MIFs) study of the lipophilicity of a series of Pt(IV) complexes 103
A step towards development of promising trypanocidal agents: Synthesis, characterization and in vitro biological evaluation of ferrocenyl Mannich base-type derivatives 103
Functionalized nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 102
Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer 102
The cisplatin-based Pt(IV)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions 100
Study of the synthesis, antiproliferative properties, and interaction with DNA and polynucleotides of cisplatin-like Pt(II) complexes containing carcinogenic polyaromatic amines 99
Host-guest inclusion systems of Pt(IV)-bis(benzoato) anticancer drug candidates and cyclodextrins 99
Application of microwave-assisted heating to the synthesis of Pt(II) complexes 99
Experimental and molecular modeling approaches to determine the lipophilicity of a Pt(IV) pro-drugs 98
Antitumor platinum(IV) pro-drugs: synthesis, characterization, cytotoxicity and QSAR analysis 98
Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug 97
Effects of dimethylsulfoxide and ethanol on the cytotoxic activity of titanocene dichloride 96
Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: How long the organic chain should be? 96
Polyanionic Biopolymers for the Delivery of Pt(II) Cationic Antiproliferative Complexes 95
A multi-methodological inquiry of the behavior of cisplatin-based Pt(IV) derivatives in the presence of bioreductants with a focus on the isolated encounter complexes 95
Cis,cis,trans-[PtIVCl2(NH3)2(perillato)2], a dual-action prodrug with excellent cytotoxic and antimetastatic activity 95
A view on multi-action Pt(IV) antitumor prodrugs 94
Synthesis, characterization and antiproliferative activity of platinum(IV) derivates of picoplatin 93
Solvolysis of a Series of Cisplatin-Like Complexes – Comparison between DNA-Biosensor and Conductivity Data 93
Bifunctional Pt-ethacrynic acid conjugates for malignant mesothelioma 92
May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs? 91
How to obtain Pt(IV) complexes suitable for conjugation to nanovectors from the oxidation of [PtCl(terpyridine)]+ 91
Synthesis and characterization of cyclohexane-1R,2R-diamine-based Pt(iv) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines 91
Classical Pt(II) anticancer complexes revised in view of drug targeting and delivery 89
An unsymmetric cisplatin-based Pt(IV) derivative containing 2-(2-propynyl)octanoate: A very efficient multi-action antitumor prodrug candidate 89
Evaluation of Platinum–Ethacrynic Acid Conjugates in the Treatment of Mesothelioma 88
Pt-195 NMR spectroscopy: A chemometric approach 88
Anthracene-terpyridine metal complexes as new G-quadruplex DNA binders 88
Application of the anthraquinone drug rhein as an axial ligand in bifunctional Pt(iv) complexes to obtain antiproliferative agents against human glioblastoma cells 87
Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin 87
Unprecedented one-pot synthesis of an unsymmetrical cisplatin-based Pt(IV)-acetamidato complex 87
Synthesis of PtIV-Biomolecule Conjugates through Click Chemistry 87
Cellular uptake of antitumor platinum(II)-complexes evaluated by means of ICP-MS technique 86
Two are (not always) better than one: the case of bifunctional platinum(IV) drugs 85
Pt(IV)/Re(I) Chitosan Conjugates as a Flexible Platform for the Transport of Therapeutic and/or Diagnostic Anticancer Agents 85
Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity: A quantitative structure-activity relationship approach 84
Pros and cons of bifunctional platinum drugs: two are (not always) better than one 84
Pt(IV) – histone deacetylase inhibitor conjugates for citotoxicity studies on MPM cells 84
Pt(IV) complexes as anticancer prodrugs 84
The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells 84
Pyrazolyl-diamine Pt(II) complexes bearing DNA-intercalating moieties: Synthesis, characterization and in vitro evaluation 83
HPLC method for the determination of monomer conversion and composition during the poly(styrene-r-methylmethacrylate) polymerization 83
Freshening up Old Methods for New Students: A Colorful Laboratory Experiment to Measure the Formation Constants of Ni(II) Complexes Containing Ethane-1,2-Diamine 82
A comparative study of the effects of platinum(II) complexes on β-amyloid aggregation: Potential neurodrug applications 82
Bidentate and tridentate pyrazolyl-containing Pt(II) complexes: synthesis, characterization and in vitro evaluation 81
Bifunctional Ethacrynic Acid – Pt Conjugates: In vitro Treatment of Malignant Pleural Mesothelioma 81
Assessment of the in vivo antiproliferative activity of a novel platinum nanoparticulate pharmacophore 79
Bioinorganic chemistry: the study of the fate of platinum-based antitumour drugs 78
Molecular Interaction Fields vs. Quantum-Mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes 78
Prediction of logP for Pt(II) and Pt(IV) complexes: Comparison of statistical and quantum-chemistry based approaches 78
Pt(iv) complexes based on cyclohexanediamines and the histone deacetylase inhibitor 2-(2-propynyl)octanoic acid: synthesis, characterization, cell penetration properties and antitumor activity 77
Assessment of the in vivo antiproliferative activity of a novel particulate pharmacophore 76
Metallo-drugs in the Treatment of Malignant Pleural Mesothelioma 76
Can the Self-Assembling of Dicarboxylate Pt(IV) Prodrugs Influence Their Cell Uptake? 76
Solvolysis of Cisplatin and N-Methylated cis-[PtCl2(en)] Complexes – Comparison between DNA-Biosensor and Conductivity Data 75
Conjugation between maleimide-containing Pt(IV) prodrugs and furan or furan-containing drug delivery vectors via Diels-Alder cycloaddition 71
Experimental determination and modeling of the lipophilicity in platinum complexes 70
Poly(methylmetacrylate) (PMMA) core-shell nanospheres act as efficient pharmacophores for the antiproliferative [PtCl3(NH3)]- complex by forming ionic couples 69
Pt(II) complexes with bidentate and tridentate pyrazolyl-containing chelators: synthesis, structural characterization and biological studies 69
Estrogenic carriers for cytotoxic Pt(II) complexes: light and shade 68
Functionalized thymidine derivatives as carriers for the γ-emitter technetium tricarbonyl moiety 68
trans,cis,cis-Bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a Prodrug Candidate for the Treatment of Oxaliplatin-Refractory Colorectal Cancer 67
Uptake of antitumor platinum(II)-complexes by cancer cells, assayed by inductively coupled plasma mass spectrometry (ICP-MS) 67
Electrochemical Biosensor Assay of the Interaction between [PtCl(n)(NH(3))(4-n)]((2-n)) (n=0-4) Complexes and ds-DNA 67
Can an Elusive Platinum(III) Oxidation State be Exposed in an Isolated Complex? 67
Studies on Log Po/w of Quinoxaline di-N-Oxides: A Comparison of RP-HPLC Experimental and Predictive Approaches 66
Unsymmetric cisplatin-based pt(Iv) conjugates containing a parp-1 inhibitor pharmacophore tested on malignant pleural mesothelioma cell lines 66
Targeting and delivery of Pt(II) antiproliferative drugs 65
Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes 65
Ethynylestradiol-Pt(II) complexes for selective drug targeting 64
Ethynylestradiol Derivatives as Carrier for Selective Vehiculation of Cytotoxic Pt(II)-Malonate and Radioactive Tc Fragments Towards Cancer Cells 63
Revisiting [PtCl2(cis-1,4-DACH)]: An Underestimated Antitumor Drug with Potential Application to the Treatment of Oxaliplatin-Refractory Colorectal Cancer 63
Platinum Complexes With Substituted Phosphines: Synthesis, Characterization, And Antiproliferative Activity 62
Nano-vectors for targeting and delivery of Pt-based anti-tumor drugs 61
Inhibition of STAT3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line 61
Synthesis and characterization of a series of Pt(IV) complexes: relationship between cytotoxicity and physico-chemical parameters 60
New Pt(II) complexes with bidentate and tridentate pyrazolyl-containing chelators: synthesis, structural studies and in vitro antitumor activity 60
Elusive Intermediates in the Breakdown Reactivity Patterns of Prodrug Platinum(IV) Complexes 60
In Vitro And In Vivo Activity Of A New Platinum Nanoparticulate Coniugate 59
Pt(iv) antitumor prodrugs: dogmas, paradigms, and realities 59
Biological Activity of Enantiomeric Complexes [PtCl2L2] (L2 = Aromatic Bisphosphanes and Aromatic Diamines) 58
Totale 8.746
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.339
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.339
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021525 0 0 0 0 0 27 141 4 150 46 140 17
2021/2022979 64 17 110 114 42 0 138 27 64 23 174 206
2022/20232.176 148 89 159 48 133 204 45 125 1.085 35 69 36
2023/2024676 48 59 57 11 103 0 130 8 9 4 146 101
2024/20251.397 16 49 88 25 70 94 158 82 312 156 73 274
2025/20262.821 338 276 470 941 553 243 0 0 0 0 0 0
Totale 11.247